• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白鞘及其与隧道式透析导管更换后后续事件的关系。

Fibrin sheath and its relation to subsequent events after tunneled dialysis catheter exchange.

作者信息

Shanaah Almothana, Brier Michael, Dwyer Amy

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine and Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OhioUniversity of Louisville and Robley Rex VA Medical Center, Louisville, KentuckyUniversity of Louisville, Louisville, Kentucky.

出版信息

Semin Dial. 2013 Nov-Dec;26(6):733-7. doi: 10.1111/sdi.12074. Epub 2013 Feb 27.

DOI:10.1111/sdi.12074
PMID:23441925
Abstract

The use of tunneled catheters (TDC) for chronic hemodialysis is frequent and often fails due to fibrin or thrombus and infection. We hypothesized that the presence of fibrin sheath in TDC increases the risk for subsequent catheter malfunction and infection. We did a retrospective review of TDC exchanges and de novo placements from January 2005 to September 2011. Demographic data, information about the catheter procedure, and radiological data were collected. Final outcome analysis included 168 procedure events. Three groups of catheter procedures were identified: catheter exchange without a fibrin sheath (CE), catheter exchange with a treated fibrin sheath (CEF), and de novo catheter placements (DCP). Fibrin sheath incidence was 47%. In the CEF group, there was no statistical difference in the incidence of subsequent infections or dysfunctions (7% and 60%, respectively), when compared with the CE group (9% and 43%, respectively), (p=0.3). Mean time to subsequent dysfunction or infection was similar for CEF and CE (135 vs. 136 days, p-value, 0.98). Fibrin sheaths are common and should be evaluated when performing TDC exchange. If the fibrin sheath is treated, there is no increased incidence in subsequent catheter dysfunction or infection compared with patients without a fibrin sheath.

摘要

长期血液透析使用带隧道的导管(TDC)很常见,但常因纤维蛋白或血栓以及感染而失败。我们推测TDC中纤维蛋白鞘的存在会增加随后导管功能障碍和感染的风险。我们对2005年1月至2011年9月期间的TDC更换和初次置管进行了回顾性研究。收集了人口统计学数据、导管操作信息和放射学数据。最终结局分析包括168例操作事件。确定了三组导管操作:无纤维蛋白鞘的导管更换(CE)、有经处理纤维蛋白鞘的导管更换(CEF)和初次导管置管(DCP)。纤维蛋白鞘发生率为47%。与CE组(分别为9%和43%)相比,CEF组随后感染或功能障碍的发生率(分别为7%和60%)无统计学差异(p=0.3)。CEF组和CE组至随后功能障碍或感染的平均时间相似(135天对136天,p值为0.98)。纤维蛋白鞘很常见,在进行TDC更换时应进行评估。如果纤维蛋白鞘得到处理,与没有纤维蛋白鞘的患者相比,随后导管功能障碍或感染的发生率不会增加。

相似文献

1
Fibrin sheath and its relation to subsequent events after tunneled dialysis catheter exchange.纤维蛋白鞘及其与隧道式透析导管更换后后续事件的关系。
Semin Dial. 2013 Nov-Dec;26(6):733-7. doi: 10.1111/sdi.12074. Epub 2013 Feb 27.
2
Tunneled dialysis catheter exchange with fibrin sheath disruption is not associated with increased rate of bacteremia.伴有纤维蛋白鞘破坏的隧道式透析导管置换与菌血症发生率增加无关。
J Vasc Access. 2015 Jan-Feb;16(1):52-6. doi: 10.5301/jva.5000301. Epub 2014 Sep 2.
3
Tunneled dialysis catheter exchange through fibrin sheath crevice vs in situ catheter exchange for the treatment of catheter dysfunction.隧道式透析导管交换经纤维蛋白鞘裂缝与原位导管交换治疗导管功能障碍。
Ther Apher Dial. 2020 Dec;24(6):695-702. doi: 10.1111/1744-9987.13473. Epub 2020 Jul 1.
4
Restoration of patency in failing tunneled hemodialysis catheters: a comparison of catheter exchange, exchange and balloon disruption of the fibrin sheath, and femoral stripping.失功带隧道血液透析导管通畅性的恢复:导管更换、纤维蛋白鞘更换及球囊破坏与股静脉剥脱术的比较
J Vasc Interv Radiol. 2006 Jun;17(6):1011-5. doi: 10.1097/01.RVI.0000223692.99800.2e.
5
Conversion of temporary hemodialysis catheters to permanent hemodialysis catheters: a retrospective study of catheter exchange versus classic de novo placement.临时血液透析导管转换为永久性血液透析导管:导管更换与经典重新置管的回顾性研究
Semin Dial. 2005 Sep-Oct;18(5):425-30. doi: 10.1111/j.1525-139X.2005.00081.x.
6
Association between disruption of fibrin sheaths using percutaneous transluminal angioplasty balloons and late onset of central venous stenosis.经皮腔内血管成形术球囊破坏纤维鞘与迟发性中心静脉狭窄的关系。
Cardiovasc Intervent Radiol. 2011 Feb;34(1):114-9. doi: 10.1007/s00270-010-9875-1. Epub 2010 May 4.
7
The natural history of tunneled hemodialysis catheters removed or exchanged: a single-institution experience.拔除或更换带隧道血液透析导管的自然病程:单机构经验
J Vasc Interv Radiol. 2007 Feb;18(2):227-35. doi: 10.1016/j.jvir.2006.12.719.
8
The catheter-challenged patient and the need to recognize the recurrently dysfunctional tunneled dialysis catheter.导管相关问题的患者以及识别反复功能失调的隧道式透析导管的必要性。
Semin Dial. 2010 Nov-Dec;23(6):648-52. doi: 10.1111/j.1525-139X.2010.00802.x.
9
Exchange over the guidewire from non-tunneled to tunneled hemodialysis catheters can be performed without patency loss.通过导丝将非隧道式血液透析导管更换为隧道式血液透析导管的操作可以在不丧失通畅性的情况下进行。
J Vasc Access. 2018 May;19(3):252-257. doi: 10.1177/1129729817747541. Epub 2018 Mar 12.
10
Hemodialysis catheter-associated fibrin sheaths: treatment with a low-dose rt-PA infusion.血液透析导管相关纤维蛋白鞘:低剂量重组组织型纤溶酶原激活剂输注治疗
J Vasc Interv Radiol. 2000 Oct;11(9):1131-6. doi: 10.1016/s1051-0443(07)61353-0.

引用本文的文献

1
Evaluating tissue plasminogen activator (tPA) in dialysis catheter dysfunction: A focus on fibrin sheath and risk factors.评估组织型纤溶酶原激活剂(tPA)在透析导管功能障碍中的作用:聚焦纤维蛋白鞘及危险因素。
Am Heart J Plus. 2025 Aug 18;58:100595. doi: 10.1016/j.ahjo.2025.100595. eCollection 2025 Oct.
2
Ultrasonic characteristics of inserted central catheter related fibroblastic sleeve.置入中心静脉导管相关纤维母细胞套的超声特征
Sci Rep. 2025 Feb 5;15(1):4319. doi: 10.1038/s41598-025-88285-w.
3
[Catheter Replacement Methods in Hemodialysis Patients With Dysfunctional Tunneled-Cuffed Catheters With Fibrin Sheaths].
[纤维蛋白鞘包裹的功能失调带隧道带涤纶套导管的血液透析患者的导管更换方法]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1283-1287. doi: 10.12182/20231160201.
4
Impact of anticoagulation and antiplatelet therapy on dialysis catheter fibrin sheath formation.抗凝和抗血小板治疗对透析导管纤维蛋白鞘形成的影响。
Diagn Interv Radiol. 2022 Nov;28(6):593-596. doi: 10.5152/dir.2022.21353.
5
Endovascular Endocarditis Within the Superior Vena Cava of a Patient With a Tunneled Catheter for Hemodialysis.一名接受带隧道血液透析导管置入术的患者上腔静脉内的血管内感染性心内膜炎
Cureus. 2022 Mar 10;14(3):e23027. doi: 10.7759/cureus.23027. eCollection 2022 Mar.
6
CT and Sonographic Findings of a Calcified Fibrin Sheath From an Umbilical Venous Catheter in a Neonate.新生儿脐静脉导管钙化纤维蛋白鞘的CT及超声表现
Cureus. 2022 Feb 3;14(2):e21865. doi: 10.7759/cureus.21865. eCollection 2022 Feb.
7
Infectious outcomes of fibrin sheath disruption in tunneled dialysis catheters.隧道式透析导管纤维鞘破裂的感染转归。
J Vasc Access. 2023 Sep;24(5):1091-1098. doi: 10.1177/11297298211070690. Epub 2022 Jan 10.
8
Rare Case of a Calcified Catheter-Related Sheath Embolizing to the Right Pulmonary Artery.钙化导管相关鞘栓子栓塞至右肺动脉的罕见病例。
Case Rep Radiol. 2020 May 20;2020:8623538. doi: 10.1155/2020/8623538. eCollection 2020.
9
Clinical and Regulatory Considerations for Central Venous Catheters for Hemodialysis.用于血液透析的中心静脉导管的临床和监管注意事项。
Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1924-1932. doi: 10.2215/CJN.14251217. Epub 2018 Oct 11.
10
Thrombotic complications and tip position of transjugular chronic dialysis catheter scheduled into superior vena cava: Findings on HR-MRCP and HR-T2WI.经颈静脉置入上腔静脉的慢性透析导管的血栓并发症及尖端位置:高分辨率磁共振胰胆管造影(HR-MRCP)和高分辨率T2加权成像(HR-T2WI)的研究结果
Medicine (Baltimore). 2017 Jun;96(26):e7135. doi: 10.1097/MD.0000000000007135.